Insider activity
Cannara Biotech Inc
Open-market and private equity trades over the last 12 months. Derivatives and opening balances excluded.
Recent transactions
| Date | Side | Name | Shares | Price |
|---|---|---|---|---|
| Jul 29, 26 | Buy | Olymbec Investments Inc. Company · CA$96,500 | 50,000 | CA$1.93 |
| Jun 02, 26 | Buy | Sosiak, Nicholas Individual · CA$28,560 | 16,800 | CA$1.70 |
| Feb 11, 26 | Sell | Krivorot, Zohar Individual · CA$699,999 | 333,333 | CA$2.10 |
| Oct 07, 25 | Buy | Stern, Derek Elan Individual · CA$6.2m | 3,462,763 | CA$1.80 |
| Oct 01, 25 | Buy | Olymbec Investments Inc. Company · CA$6.2m | 3,462,763 | CA$1.80 |
| May 06, 25 | Buy | Olymbec Investments Inc. Company · CA$349,950 | 250,000 | CA$1.40 |
Recent insider activity at Cannara Biotech Inc suggests a strong vote of confidence from its largest shareholder.
In the last two weeks, Cannara Biotech Inc (LOVE.V) has seen some notable insider activity, particularly from Olymbec Investments Inc., which has made a significant purchase of shares. This transaction could indicate a bullish sentiment about the company's future prospects.
Investor takeaway: While insider buying can reflect confidence in a company's direction, it's essential to consider it as just one factor in your investment decision-making process.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Cannara Biotech Inc
LOVE.V
LOVE.V
Cannara Biotech Inc
WealthAwesomeMarket cap
$181.03M
P/E
15.8x
52W high
$2.07
52W low
$1.06
1W change
+0.00%
Beta
0.34
Analyst Price Targets
Based on analyst covering LOVE
Wall Street analysts forecast LOVE stock price to rise 79.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.38
+79.5% Upside
Current Price
C$1.88
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LOVE's historical volatility
30-Day Vol
47.9%
Annualized
90-Day Vol
42.2%
Annualized
Trend (90d)
+30.9%
Annualized drift
90d Mean
C$2.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.90 | C$1.61 – C$2.24 |
| 60 trading days | C$1.97 | C$1.56 – C$2.49 |
| 90 trading days | C$2.04 | C$1.54 – C$2.72 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Insider Purchase Amounts to CA$96,500
Advertisement
Olymbec Investments Inc. acquired 50,000 shares at CA$1.93, reflecting a significant commitment to Cannara Biotech Inc. in a short time frame.
Bull case
The recent purchase of 50,000 shares by Olymbec Investments Inc. suggests that insiders believe Cannara Biotech is undervalued or on the verge of positive developments. This kind of confidence might encourage retail investors to take a closer look at the company.
Bear case
Even with the insider buying, it’s important to remember that this single transaction doesn’t guarantee future performance. Investors should weigh this information alongside other financial indicators and market conditions.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
